Quick read
agenusbio.com looks like health & fitness. Traffic estimates are limited, so use the trust and structure modules first. Current AI trust scoring is 5/100.
What to do next
39/56 fields populated (70%)
Providers with missing fields
visual: 4/4
All expected fields present
meta: 3/3
All expected fields present
seo: 5/5
All expected fields present
dns: 4/4
All expected fields present
ads: 5/5
All expected fields present
publisher: 3/5
Missing: directCount, resellerCount
files: 2/3
Missing: robotsSitemapUrls
traffic: 0/10
Missing: monthlyVisits, globalRank, countryRank, bounceRate, avgVisitDuration, pagesPerVisit, topCountry, topRegions, topKeywords, trafficSources
whois: 6/6
All expected fields present
radar: 0/4
Missing: globalRank, rankBucket, categories, sourceTimestamp
ai: 7/7
All expected fields present
Why this module matters
Use the business tab to understand trust, monetization, audience fit, and brand posture before you spend time on outreach, partnerships, or competitive teardown work.
Agenus is a biotechnology company developing immunotherapies to treat cancer. They focus on leveraging the immune system to defeat cancer through innovative therapeutic approaches, with emphasis on expanding patient access to their treatments including Botensilimab and Balstilimab.
Monetization Signals
Biopharmaceutical R&D model detected
Low trust with 5/100 score
Cancer patients, oncologists, healthcare providers, investors, and medical researchers seeking advanced immunotherapy treatments
Keep exploring
Good pSEO pages should not strand the visitor. These links keep the journey moving through adjacent directories and comparable live reports.